EUVIMEDEUVIMED entdecken
Metaanalyse

Omega-3 fatty acids, specialized pro-resolving mediators, and depression: A mechanistic meta-analysis of precursors and clinical implications

Ayesha Zafar Iqbal, Aimal Khan, Ikbal Andrian Malau, Suet-Kei Wu, Jane Pei-Chen Chang, Chin Cheng, Ming-Jun Tsai, Fan Wang, Kuan-Pin Su

Brain, Behavior, and Immunity · 2026-11 · 138 · 106922

DOI: 10.1016/j.bbi.2026.106922 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Brain, Behavior, and Immunity, 2026-11. Verfasst von Ayesha Zafar Iqbal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Mind-Body Interface Research Center (MBI Lab & Care), China Medical University Hospital, Taichung, Taiwan; Graduate Institute of Nutrition, China Med…. Hauptthemen laut MEDLINE: Antidepressive Agents, Depression, Dietary Supplements, Fatty Acids, Omega-3. Die Arbeit nennt 88 Literaturangaben. Gefördert von: National Science and Technology Council, Tainan Municipal An Nan Hospital, China Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Omega-3 polyunsaturated fatty acids (n-3 PUFAs), especially eicosapentaenoic acid (EPA), exhibit adjunctive antidepressant efficacy despite negligible detectable levels in the brain. Emerging evidence implicates specialized pro‑resolving mediators (SPMs); bioactive n-3 PUFA metabolites offer a coherent pathway by actively resolving inflammation, enhancing tissue repair, and supporting neuronal function. To test whether n‑3 PUFA supplementation activates pro‑resolving biology in humans, this meta‑analysis quantified effects on circulating SPM precursors. METHODS: We systematically searched PubMed, EMBASE, Web of Science, GOED, and the Cochrane Library (up to May 18, 2026) to identify RCTs examining the impact of n-3 PUFAs supplementation on circulating SPM precursors 18-hydroxyeicosapentaenoic acid (18-HEPE) and 17-hydroxydocosahexaenoic acid (17-HDHA). Meta-analysis was performed using Review Manager 5.4.1 with random-effects models. RESULTS: Eleven RCTs, comprising 810 participants, were included. N-3 PUFAs supplementation significantly and robustly increased the concentrations of both circulating SPM precursors: 18-HEPE (SMD = 1.05, 95% CI 0.54-1.55, Z = 4.08, P = 0.0001) and 17-HDHA (SMD = 0.69, 95% CI 0.19-1.18, Z = 2.72, P = 0.006). Importantly, subgroup analyses revealed that this increase was selectively amplified in patient populations characterized by a significant inflammatory, metabolic, and oxidative burden, including peripheral artery disease (PAD), chronic kidney disease (CKD), MDD with comorbid obesity, and pregnancy, but was negligible in healthy infants. CONCLUSION: N-3 PUFA supplementation significantly increased circulating 18-HEPE and 17-HDHA, indicating greater availability of upstream EPA- and DHA-derived SPM precursors across mixed human populations. However, whether these precursor changes translate into increased downstream SPM production or clinical antidepressant effects remains uncertain and requires dedicated trials in MDD populations. PROSPERO registration number: CRD420251138493.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsDepressionDietary SupplementsFatty Acids, Omega-3Specialized Pro-Resolving MediatorsFemaleHumansDocosahexaenoic AcidsEicosapentaenoic AcidInflammation

Stichwörter der Autor:innen

17-HDHA18-HEPEInflammationMajor depressive disorderOmega-3 polyunsaturated fatty acids

Substanzen

Antidepressive AgentsDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3

Autor:innen und Institutionen

  • Mind-Body Interface Research Center (MBI Lab & Care), China Medical University Hospital, Taichung, Taiwan; Graduate Institute of Nutrition, China Medical University, Taichung, Taiwan.
  • Mind-Body Interface Research Center (MBI Lab & Care), China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan.
  • Mind-Body Interface Research Center (MBI Lab & Care), China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan; Child Psychiatry Division, Department of Psychi…
  • Good Day Psychiatric Clinic, Taichung 427, Taiwan.
  • School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Beijing Hui-Long-Guan Hospital, Peking University, China.

Förderung

  • National Science and Technology Council
  • Tainan Municipal An Nan Hospital
  • China Medical University
  • Executive Yuan Republic of China Ministry of Education
  • China Medical University Hospital Taichung Hospital Clinical Trial Center

Zitieren

APA

Iqbal, A. Z., Khan, A., Malau, I. A., Wu, S. K., Chang, J. P., Cheng, C., Tsai, M. J., Wang, F., & Su, K. P. (2026). Omega-3 fatty acids, specialized pro-resolving mediators, and depression: A mechanistic meta-analysis of precursors and clinical implications. Brain, Behavior, and Immunity, 138, 106922. https://doi.org/10.1016/j.bbi.2026.106922

Vancouver

Iqbal AZ, Khan A, Malau IA, Wu SK, Chang JP, Cheng C, et al. Omega-3 fatty acids, specialized pro-resolving mediators, and depression: A mechanistic meta-analysis of precursors and clinical implications. Brain, Behavior, and Immunity. 2026;138:106922. doi:10.1016/j.bbi.2026.106922

BibTeX
@article{Iqbal2026,
  author = {Iqbal, Ayesha Zafar and Khan, Aimal and Malau, Ikbal Andrian and Wu, Suet-Kei and Chang, Jane Pei-Chen and Cheng, Chin and Tsai, Ming-Jun and Wang, Fan and Su, Kuan-Pin},
  title = {Omega-3 fatty acids, specialized pro-resolving mediators, and depression: A mechanistic meta-analysis of precursors and clinical implications},
  journal = {Brain, Behavior, and Immunity},
  year = {2026},
  volume = {138},
  pages = {106922},
  doi = {10.1016/j.bbi.2026.106922}
}
Kostenlos starten →